文献速递主动脉疾病

桥接EVAR后延迟开放重建治疗感染性自体腹主动脉瘤

Bridge Endovascular Aneurysm Repair Followed by Delayed Open Reconstruction for Infected Native Abdominal Aortic Aneurysm.
PubMed 文献 · Ann Vasc Surg · 2026-10-05

单中心回顾性研究评估桥接EVAR联合延长抗菌治疗及延迟开放重建治疗感染性自体腹主动脉瘤的策略。8例患者中位EVAR至确定性重建间隔79.5天,1年生存率87.5%、3年65.6%,幸存者无感染复发或移植物感染。

要点

  • 桥接EVAR可为感染控制和生理恢复争取时间
  • 延迟开放重建前需延长抗菌治疗
  • 小样本可行性结果,需更大对比研究验证

核心结论

  • 桥接EVAR后延长抗菌治疗并延迟开放重建在幸存者中可行且实现持久感染控制。

研究设计与样本

  • 9例诊断感染性自体腹主动脉瘤,其中8例接受桥接EVAR后延迟开放重建的分阶段治疗。

主要发现

  • 平均年龄68.1岁,男性5例(62.5%),血培养阳性6例(75.0%)。
  • EVAR至确定性重建中位间隔79.5天(范围55-105天)。
  • 7例感染控制后行原位人工血管重建,1例持续感染行自体股静脉重建。
  • 中位随访20.5个月(范围1-39个月)期间2例死亡,估计1年总生存率87.5%、3年65.6%。
  • 幸存患者中未观察到感染复发、移植物感染或移植物相关再干预。

临床怎么用

  • 对感染性自体腹主动脉瘤高生理风险患者,可考虑桥接EVAR争取感染控制与生理恢复时间。
  • 桥接期间需延长抗菌治疗,感染控制后行延迟开放重建。

局限性

  • 样本量小(8例接受分阶段治疗),为单中心回顾性描述性研究。
  • 缺乏对照组,无法比较分阶段策略与急诊开放修复等其他策略的优劣。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Infected native abdominal aortic aneurysm (INAA) is a life-threatening condition for which emergency open repair may carry substantial physiologic risk. This study evaluated a staged strategy using endovascular aneurysm repair (EVAR) for initial aneurysm exclusion, followed by prolonged antimicrobial therapy and delayed definitive open reconstruction. METHODS: We retrospectively reviewed consecutive patients with INAA treated at a single tertiary referral center between January 2020 and December 2025. Patients undergoing bridge EVAR followed by delayed EVAR explantation and open reconstruction after infection control were included. Clinical characteristics, operative details, postoperative complications, infection-related outcomes, and survival were assessed descriptively. RESULTS: Nine patients were diagnosed with INAA, of whom eight underwent staged treatment. Mean age was 68.1 years, 5 patients (62.5%) were male, and blood cultures were positive in six (75.0%). The median interval from EVAR to definitive reconstruction was 79.5 days (range, 55-105 days). 7 patients underwent in situ prosthetic graft reconstruction after infection control; one patient with persistent infection underwent autologous femoral vein reconstruction. During a median follow-up of 20.5 months (range, 1-39 months), 2 patients died. Estimated overall survival was 87.5% at 1 year and 65.6% at 3 years. No recurrent infection, graft infection, or graft-related reintervention was observed among surviving patients. CONCLUSION: In this small cohort managed with a staged institutional strategy, bridge EVAR followed by prolonged antimicrobial therapy and delayed open reconstruction was feasible and achieved durable infection control among survivors. This strategy may provide time for infection control and physiologic recovery before definitive reconstruction; larger comparative studies are required.

来源:Ann Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Kwak JW, Cho SB, Kim HK, et al. Bridge Endovascular Aneurysm Repair Followed by Delayed Open Reconstruction for Infected Native Abdominal Aortic Aneurysm. Ann Vasc Surg. 2026. PMID: 42833582. doi:10.1016/j.avsg.2026.09.049

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。